Back to top
more

Progyny (PGNY)

(Real Time Quote from BATS)

$27.37 USD

27.37
1,368,201

-0.18 (-0.65%)

Updated May 17, 2024 09:40 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

The Joint (JYNT) Acquires 4 Franchised Facilities, Down 5%

The Joint (JYNT) anticipates the new acquisition value in Scottsdale to match the price of its previous purchases.

Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 150% and 2.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Progyny (PGNY) to Report a Decline in Earnings: What to Look Out for

Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVTR vs. PGNY: Which Stock Is the Better Value Option?

AVTR vs. PGNY: Which Stock Is the Better Value Option?

OCDX vs. PGNY: Which Stock Should Value Investors Buy Now?

OCDX vs. PGNY: Which Stock Is the Better Value Option?

Progyny (PGNY) Surpasses Q4 Earnings Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Progyny (PGNY) Q4 Earnings Expected to Decline

Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Progyny (PGNY) Upgraded to Buy: Here's What You Should Know

Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Progyny (PGNY) Soars to 52-Week High, Time to Cash Out?

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny (PGNY) Q3 Earnings Beat Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 142.86% and -2.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Earnings Expected to Grow: Should You Buy?

Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Zacks Industry Outlook Highlights: HealthEquity, Progyny, Surgery Partners, ModivCare and Agiliti

Urmimala Biswas headshot

5 Medical Services Stocks Countering Industry Headwinds

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most. However, falling healthcare spending may disrupt the trend.

Progyny (PGNY) Beats Q2 Earnings Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 111.11% and -0.24%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth

Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade

Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks.com featured highlights include: Digital Turbine, 360 DigiTech, Progyny and E.W. Scripps

Zacks.com featured highlights include: Digital Turbine, 360 DigiTech, Progyny and E.W. Scripps

Nitish Marwah headshot

4 Stocks With High Net Income Ratio to Scoop Up

APPS, QFIN, PGNY, and SSP have qualified the screen for high net income ratio stocks.

Progyny (PGNY) Sees Hammer Chart Pattern: Time to Buy?

Progyny (PGNY) has been struggling lately, but the selling pressure may be coming to an end soon.

Here's Why Progyny (PGNY) is a Great Momentum Stock to Buy

Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Progyny's (PGNY) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Progyny, Inc. (PGNY)

Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy?

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Here's What Could Help Progyny (PGNY) Maintain Its Recent Price Strength

Progyny (PGNY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Progyny (PGNY) Q1 Earnings and Revenues Surpass Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 87.50% and 0.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Q3 Earnings Meet Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 0.00% and 6.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?